investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining the impact of clonal evolution on chronic lymphocytic leukemia
Catherine Ju-Ying Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Jeffrey S Miller
Viral priming and targeting NK cells against solid tumor malignancies
Leukaemia
Hematology and hematologic malignancies
Joseph H Antin
A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
Leukaemia
Kimberly Stegmaier
Validating Syk as a Target for AML Therapy
Leukaemia
Margaret A Goodell
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
Leukaemia
Hao Yuan Kueh
Single cell analysis of hematopoietic cell fate determination
Leukaemia
Ronen Marmorstein
Structure and Function of Protein Acetyltransferases
Leukaemia
Marina Y Konopleva
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
Leukaemia
Nya D Nelson
Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita
Leukaemia
Pathology
Yves Pommier
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
Leukaemia